Randomized Controlld Trial of Dementia Education Resources for Action
George Mason University · NCT07545577
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- June 16, 2026
- Record last updated
- September 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). We hypothesize that participants who have completed the DERA will have improved ADRD knowledge and self-efficacy in related service and reduced stigma against ADRD and people affected.
Being studied: DERA Online Training Program
Conditions: Alzheimer's Disease and Related Dementia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18 years or older
- Currently working as a community health worker or serving in a community health worker-related role
- Able to read and understand English
- Has access to the internet and a computer, tablet, or smartphone to complete the online training and surveys
- Willing and able to provide informed consent
Exclusion Criteria
- Previously completed the DERA training program
- Unable to complete study procedures in English
- Unable to access the online training platform or study surveys
Recruiting US locations
Online
Fairfax, VA 22030
Site contact: Alicia Hong · 703-993-1929 · yhong22@gmu.edu
Study contacts (from the official record)
- Alicia Hong · 7039931929 · yhong22@gmu.edu
Similar studies in Virginia
All neurology studies in Virginia →- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Vienna, VA + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Biohaven Therapeutics Ltd.
- Location
- Henrico, VA + 24 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
AbbVie
- Location
- Charlottesville, VA + 17 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Rapport Therapeutics Inc.
- Location
- Richmond, VA + 13 other US sites
- Eligibility basics
- Ages 18–75